undergoing legal abortion in the 7th\p=n-\15th week of gestation and tissue from the lower uterine segment was excised at elective Casearean section in the 38th\p=n-\40th week. The specimens were incubated with [3H] proline in the presence of relaxin or prostaglandin E2 (PGE2). Relaxin had a concentration related inhibitory effect on the radiolabelling in the 7th\p=n-\9thweek but failed to influence the amino acid uptake in the 10th\p=n-\15th week of pregnancy. PGE2 had the inverse effect, i.e. no influence in the former group but reduced incorporation of proline in the latter group of patients. Incubation of tissue from the lower uterine segment showed a similar response as that of the early pregnant cervix. It is concluded that relaxin has a significant influence on [3H]proline incorporation by cervical and uterine tissue under in vitro experimental conditions. Softening and lengthening of the ligament of the pubic symphysis was the first identified effect of the ovarian polypeptide hormone relaxin (Hisaw 1926) . It was not until considerably later it was realized that relaxin also had a softening and dilating action on another collagenous structure of the reproductive tract, the cervix. This action has been demonstrated in a variety of species, such as the rat, mouse, sow, cow and monkey (Graham & Dracy 1952; Zarrow et al. 1956; (Stone et al. 1959 ). These studies were, however, (1963) .
The reduced alkylated porcine relaxin was hydrolyzed with 6 M HC1; amino acid analysis indicated that cysteine residues had been converted to carboxymethyl cysteine. The reduced and akylated relaxin was inactive in guinea pig palpation and mouse pubic ligament bioassays and in the Ré antibody radioimmunoassay (Sherwood & O'Byrne 1974 (Wolf 1968 (Fig. 3) . Earlier studies from this laboratory showed that PGE2 increases [3H]proline incorporation into cer¬ vical tissue in the 7th-8th week but decreases the radiolabelling in the 12th-13th week of gestation (Norström 1982) . The difference in response to relaxin and PGE2 at different weeks in the first trimester of pregnancy was re-investigated in the present study. Cervical specimens were incubated with relaxin or PGE2 in the way that each com¬ pound was tested on tissue from the same patient. The data on proline incorporation again showed that relaxin reduced the uptake in the beginning of the first trimester (P < 0.01) but had no effect in the 10th-13th week of gestation. The correspond¬ ing values with PGE2 were opposite to those of relaxin, i.e. no effect in the former and decreased uptake of [3H]proline (P < 0.05) in the latter pe¬ riod of gestation (Fig. 4) . 
Discussion
Although the dilatability of the cervix in a variety of laboratory animals is enhanced by the addition of relaxin to regimens of steroid treatment the histological and ultrastructural features observed in these cervices are indistinguishable from those elicited by steroids alone. Hypertrophy of fibro¬ blasts and separation and spacing of the collagen bundles seem to be common alterations (Leppi 1964; Leppi & Kinnison 1971) . This remodelling of the collagenous framework is likely to involve both destruction and new synthesis of collagen. Relaxin appears to stimulate the production or release of collagenolytic enzymes and also to cause an in¬ crease in the non-collagenous matrix of cervical connective tissue Steinetz et al. 1980 The relaxin concentrations used in the present study are by far higher than those in the human circulation (Quagliarello et al. 1979 ). However, it should be remembered that relaxin is secreted from the decidua resulting in a high local concen¬ tration of relaxin (Bigazzi et al. 1980) . It is a long way between the biochemical observa¬ tions presented in this study and effects of relaxin in the clinical situation. However, in view of the difficulties involved in the evaluation of clinical trials aiming at softening the human cervix by relaxin it might be of interest that human cervical and uterine connective tissue is influenced by re¬ laxin under in vitro experimental conditions.
